These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

197 related articles for article (PubMed ID: 19223902)

  • 1. Relation between outcomes and localisation of p-mTOR expression in gastric cancer.
    Murayama T; Inokuchi M; Takagi Y; Yamada H; Kojima K; Kumagai J; Kawano T; Sugihara K
    Br J Cancer; 2009 Mar; 100(5):782-8. PubMed ID: 19223902
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Localisation of phosphorylated mTOR expression is critical to tumour progression and outcomes in patients with endometrial cancer.
    Yoshida Y; Kurokawa T; Horiuchi Y; Sawamura Y; Shinagawa A; Kotsuji F
    Eur J Cancer; 2010 Dec; 46(18):3445-52. PubMed ID: 20926288
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Overexpression of phosphorylated mammalian target of rapamycin predicts lymph node metastasis and prognosis of chinese patients with gastric cancer.
    Yu G; Wang J; Chen Y; Wang X; Pan J; Li G; Jia Z; Li Q; Yao JC; Xie K
    Clin Cancer Res; 2009 Mar; 15(5):1821-9. PubMed ID: 19223493
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prognostic role of p-mTOR expression in cancer tissues and metastatic lymph nodes in pT2b gastric cancer.
    An JY; Kim KM; Choi MG; Noh JH; Sohn TS; Bae JM; Kim S
    Int J Cancer; 2010 Jun; 126(12):2904-13. PubMed ID: 19739122
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mechanisms of GOLPH3 associated with the progression of gastric cancer: a preliminary study.
    Peng J; Fang Y; Tao Y; Li K; Su T; Nong Y; Xie F; Lai M
    PLoS One; 2014; 9(10):e107362. PubMed ID: 25286393
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Phosphorylated Mammalian Target of Rapamycin p-mTOR Is a Favorable Prognostic Factor than mTOR in Gastric Cancer.
    Cao GD; Xu XY; Zhang JW; Chen B; Xiong MM
    PLoS One; 2016; 11(12):e0168085. PubMed ID: 28005970
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mammalian target of rapamycin is activated in human gastric cancer and serves as a target for therapy in an experimental model.
    Lang SA; Gaumann A; Koehl GE; Seidel U; Bataille F; Klein D; Ellis LM; Bolder U; Hofstaedter F; Schlitt HJ; Geissler EK; Stoeltzing O
    Int J Cancer; 2007 Apr; 120(8):1803-10. PubMed ID: 17230506
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The PI3K/AKT/mTOR signalling pathway is active in salivary gland cancer and implies different functions and prognoses depending on cell localisation.
    Ettl T; Schwarz-Furlan S; Haubner F; Müller S; Zenk J; Gosau M; Reichert TE; Zeitler K
    Oral Oncol; 2012 Sep; 48(9):822-30. PubMed ID: 22445095
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The role of mTOR and phospho-p70S6K in pathogenesis and progression of gastric carcinomas: an immunohistochemical study on tissue microarray.
    Xiao L; Wang YC; Li WS; Du Y
    J Exp Clin Cancer Res; 2009 Dec; 28(1):152. PubMed ID: 20003385
    [TBL] [Abstract][Full Text] [Related]  

  • 10. PP242 suppresses cell proliferation, metastasis, and angiogenesis of gastric cancer through inhibition of the PI3K/AKT/mTOR pathway.
    Xing X; Zhang L; Wen X; Wang X; Cheng X; Du H; Hu Y; Li L; Dong B; Li Z; Ji J
    Anticancer Drugs; 2014 Nov; 25(10):1129-40. PubMed ID: 25035961
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Activation of the Akt-mTOR pathway and receptor tyrosine kinase in patients with solitary fibrous tumors.
    Yamada Y; Kohashi K; Fushimi F; Takahashi Y; Setsu N; Endo M; Yamamoto H; Tokunaga S; Iwamoto Y; Oda Y
    Cancer; 2014 Mar; 120(6):864-76. PubMed ID: 24353015
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prognostic value of co-expression of STAT3, mTOR and EGFR in gastric cancer.
    Inokuchi M; Murayama T; Hayashi M; Takagi Y; Kato K; Enjoji M; Kojima K; Kumagai J; Sugihara K
    Exp Ther Med; 2011 Mar; 2(2):251-256. PubMed ID: 22977493
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dietary energy restriction modulates the activity of AMP-activated protein kinase, Akt, and mammalian target of rapamycin in mammary carcinomas, mammary gland, and liver.
    Jiang W; Zhu Z; Thompson HJ
    Cancer Res; 2008 Jul; 68(13):5492-9. PubMed ID: 18593953
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prognostic implication of TSC1 and mTOR expression in gastric carcinoma.
    Byeon SJ; Han N; Choi J; Kim MA; Kim WH
    J Surg Oncol; 2014 Jun; 109(8):812-7. PubMed ID: 24615476
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prognostic significance of PAK4 expression in gastric cancer.
    Kobayashi K; Inokuchi M; Takagi Y; Otsuki S; Fujimori Y; Sato Y; Yanaka Y; Higuchi K; Aburatani T; Tomii C; Uetake H; Kojima K; Kawano T
    J Clin Pathol; 2016 Jul; 69(7):580-5. PubMed ID: 26614788
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Phospho-mTOR and phospho-4EBP1 in endometrial adenocarcinoma: association with stage and grade in vivo and link with response to rapamycin treatment in vitro.
    Darb-Esfahani S; Faggad A; Noske A; Weichert W; Buckendahl AC; Müller B; Budczies J; Röske A; Dietel M; Denkert C
    J Cancer Res Clin Oncol; 2009 Jul; 135(7):933-41. PubMed ID: 19107520
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Positive prognostic value of HER2-HER3 co-expression and p-mTOR in gastric cancer patients.
    Cao GD; Chen K; Chen B; Xiong MM
    BMC Cancer; 2017 Dec; 17(1):841. PubMed ID: 29233126
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A detailed immunohistochemical analysis of the PI3K/AKT/mTOR pathway in lung cancer: correlation with PIK3CA, AKT1, K-RAS or PTEN mutational status and clinicopathological features.
    Trigka EA; Levidou G; Saetta AA; Chatziandreou I; Tomos P; Thalassinos N; Anastasiou N; Spartalis E; Kavantzas N; Patsouris E; Korkolopoulou P
    Oncol Rep; 2013 Aug; 30(2):623-36. PubMed ID: 23728071
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Activation of the Akt/mammalian target of rapamycin/4E-BP1 pathway by ErbB2 overexpression predicts tumor progression in breast cancers.
    Zhou X; Tan M; Stone Hawthorne V; Klos KS; Lan KH; Yang Y; Yang W; Smith TL; Shi D; Yu D
    Clin Cancer Res; 2004 Oct; 10(20):6779-88. PubMed ID: 15501954
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Association between high expression of phosphorylated Akt and mammalian target of rapamycin and improved survival in salivary gland adenoid cystic carcinoma.
    Ouyang DQ; Liang LZ; Ke ZF; Zheng GS; Weng DS; Yang WF; Su YX; Liao GQ
    Head Neck; 2017 Jun; 39(6):1145-1154. PubMed ID: 28230926
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.